<DOC>
	<DOC>NCT01633658</DOC>
	<brief_summary>The investigators hypothesize that native vitamin D will have more variability in 25(OH)D dose response when compared to a given equipotent dose of 25-hydroxyvitamin D3. This will be a single blind, active control, pharmacokinetic study of 625 μg 25(OH)D given orally or 2500 μg native vitamin D given orally.</brief_summary>
	<brief_title>The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3</brief_title>
	<detailed_description>Single blind, active control, pharmacokinetic study of 625 μg 25(OH)D given orally or 2500 μg native vitamin D given orally.</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Hydroxycholecalciferols</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Ten men and women in each group, aged 2060. History of hypercalcemia, vitamin D supplement use &gt; 800 IU daily, BMI &gt; 30, gastrointestinal malabsorption (from celiac sprue, colitis, surgery, etc.), kidney disease or liver disease, use of steroids in any form, anticonvulsants, antibiotics, acute illness, or vacation planned to "sunny climate"</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>vitamin D</keyword>
</DOC>